Prelude Therapeutics Inc (PRLD)
NASDAQ
News
Market Data
Register for real-time alerts, custom portfolio, and market movers
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |||
| Total Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -29.46M | -30.41M | -33.39M | -29.12M | -32.4M | -33.39M | -37.38M | -34.34M |
| Pre Tax Income | -27.37M | -29.96M | -28.64M | -27.72M | -30.43M | -30.61M | -33.08M | -31.43M |
| Net Income | -27.37M | -29.96M | -28.64M | -27.72M | -30.43M | -30.61M | -33.08M | -31.43M |
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBIT | -27.37M | -29.96M | -28.64M | -27.72M | -30.43M | -30.61M | -33.08M | -31.43M |
| EBITDA | -29.14M | -30.07M | -33.02M | -28.84M | -32.12M | -33.11M | -37.05M | -33.92M |
| Year End December 30 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -14.98M | -28.11M | -58.76M | -113.74M | -123.54M | -132.28M |
| Pre Tax Income | -14.68M | -27.57M | -56.93M | -111.69M | -115.44M | -121.83M |
| Net Income | -14.68M | -27.57M | -56.93M | -111.69M | -115.44M | -121.83M |
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | -5.332 | -7.539 | -0.651 | -1.173 | -1.205 | -1.11 |
| EBIT | -14.68M | -27.57M | -56.93M | -111.69M | -115.44M | -121.83M |
| EBITDA | -14.88M | -27.73M | -58.22M | -112.82M | -122.22M | -131.11M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
